These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 18313879)

  • 1. Use of pharmacodynamic endpoints for the evaluation of levofloxacin for the treatment of acute maxillary sinusitis.
    Ambrose PG; Anon JB; Bhavnani SM; Okusanya OO; Jones RN; Paglia MR; Kahn J; Drusano GL
    Diagn Microbiol Infect Dis; 2008 May; 61(1):13-20. PubMed ID: 18313879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral garenoxacin in the treatment of acute bacterial maxillary sinusitis: a Phase II, multicenter, noncomparative, open-label study in adult patients undergoing sinus aspiration.
    Lopez Sisniega J; Profant M; Kostrica R; Waskin H
    Clin Ther; 2007 Aug; 29(8):1632-44. PubMed ID: 17919545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serial sinus aspirate samples during high-dose, short-course levofloxacin treatment of acute maxillary sinusitis.
    Anon JB; Paglia M; Xiang J; Ambrose PG; Jones RN; Kahn JB
    Diagn Microbiol Infect Dis; 2007 Jan; 57(1):105-7. PubMed ID: 17178300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Open-label assessment of levofloxacin for the treatment of acute bacterial sinusitis in adults.
    Sydnor TA; Kopp EJ; Anthony KE; LoCoco JM; Kim SS; Fowler CL
    Ann Allergy Asthma Immunol; 1998 Apr; 80(4):357-62. PubMed ID: 9564988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Commentary on "Use of pharmacodynamic endpoints for the evaluation of levofloxacin for the treatment of acute maxillary sinusitis" by Ambrose et al.
    Gwaltney JM
    Diagn Microbiol Infect Dis; 2008 May; 61(1):21-2. PubMed ID: 18375085
    [No Abstract]   [Full Text] [Related]  

  • 6. Use of pharmacodynamic end points in the evaluation of gatifloxacin for the treatment of acute maxillary sinusitis.
    Ambrose PG; Anon JB; Owen JS; Van Wart S; McPhee ME; Bhavnani SM; Piedmonte M; Jones RN
    Clin Infect Dis; 2004 Jun; 38(11):1513-20. PubMed ID: 15156435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrapulmonary pharmacokinetics and pharmacodynamics of high-dose levofloxacin in healthy volunteer subjects.
    Conte JE; Golden JA; McIver M; Zurlinden E
    Int J Antimicrob Agents; 2006 Aug; 28(2):114-21. PubMed ID: 16837169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An open-label, double tympanocentesis study of levofloxacin therapy in children with, or at high risk for, recurrent or persistent acute otitis media.
    Arguedas A; Dagan R; Pichichero M; Leibovitz E; Blumer J; McNeeley DF; Melkote R; Noel GJ
    Pediatr Infect Dis J; 2006 Dec; 25(12):1102-9. PubMed ID: 17133154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of a novel, single-dose azithromycin microsphere formulation versus 10 days of levofloxacin for the treatment of acute bacterial sinusitis in adults.
    Murray JJ; Emparanza P; Lesinskas E; Tawadrous M; Breen JD
    Otolaryngol Head Neck Surg; 2005 Aug; 133(2):194-200. PubMed ID: 16087013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study of pharmacokinetics/pharmacodynamics of levofloxacin].
    Zhang J; Yu JC; Shi YG; Zhou L; Ye XY; Zhu DM; Zhang YY
    Zhonghua Yi Xue Za Zhi; 2005 Jul; 85(27):1926-32. PubMed ID: 16255991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Levofloxacin in the treatment of acute and bacteriologically documented sinusitis with high risk of complications].
    Gehanno P; Pessey JJ; Serrano E
    Med Mal Infect; 2005 Jun; 35(6):335-43. PubMed ID: 16023320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An open label, randomized comparative study of levofloxacin and amoxicillin/clavulanic acid in the treatment of purulent sinusitis in adult Thai patients.
    Jareoncharsri P; Bunnag C; Fooanant S; Tunsuriyawong P; Voraprayoon S; Srifuengfung S; Dhiraputra C
    Rhinology; 2004 Mar; 42(1):23-9. PubMed ID: 15072030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacodynamic analysis of ceftriaxone, gatifloxacin,and levofloxacin against Streptococcus pneumoniae with the use of Monte Carlo simulation.
    Frei CR; Burgess DS
    Pharmacotherapy; 2005 Sep; 25(9):1161-7. PubMed ID: 16164390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrapulmonary pharmacodynamics of high-dose levofloxacin in subjects with chronic bronchitis or chronic obstructive pulmonary disease.
    Conte JE; Golden JA; McIver M; Little E; Zurlinden E
    Int J Antimicrob Agents; 2007 Nov; 30(5):422-7. PubMed ID: 17716873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacodynamic target attainment analysis against Streptococcus pneumoniae using levofloxacin 500 mg, 750 mg and 1000 mg once daily in plasma (P) and epithelial lining fluid (ELF) of hospitalized patients with community acquired pneumonia (CAP).
    Noreddin AM; Marras TK; Sanders K; Chan CK; Hoban DJ; Zhanel GG
    Int J Antimicrob Agents; 2004 Nov; 24(5):479-84. PubMed ID: 15519481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial treatment of sinusitis.
    Bamberger DM
    Semin Respir Infect; 1991 Jun; 6(2):77-84. PubMed ID: 1771306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacteriological efficacy of 5-day therapy with telithromycin in acute maxillary sinusitis.
    Buchanan P; Roos K; Tellier G; Rangaraju M; Leroy B
    Int J Antimicrob Agents; 2005 Mar; 25(3):237-46. PubMed ID: 15737519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacteriological findings and antimicrobial susceptibility in chronic sinusitis with nasal polyp.
    Kim HJ; Lee K; Yoo JB; Song JW; Yoon JH
    Acta Otolaryngol; 2006 May; 126(5):489-97. PubMed ID: 16698698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Sinusal penetration of amoxicillin-clavulanic acid. Formulation 1 g./125 mg., twice daily versus formulation 500 mg./125 mg., three times daily].
    Jehl F; Klossek JM; Peynegre R; Serrano E; Castillo L; Bobin S; Desprez D; Renault C; Neel V; Rouffiac E; Borie C
    Presse Med; 2002 Oct; 31(34):1596-603. PubMed ID: 12426976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A trial of high-dose, short-course levofloxacin for the treatment of acute bacterial sinusitis.
    Poole M; Anon J; Paglia M; Xiang J; Khashab M; Kahn J
    Otolaryngol Head Neck Surg; 2006 Jan; 134(1):10-7. PubMed ID: 16399173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.